ALIM Related Momentum Movers
-
pSivida (PSDV) Rips Again; Traders Eye Further European Approval for ILLUVIEN (ALIM)
-
Alimera Sciences (ALIM) Moves up 130% on Week Due to Positive Results for Decentralized Procedure for ILUVIEN
-
pSivida (PSDV) Announces Positive Phase 3 FAME study of ILUVIEN (ALIM)
-
Alimera Sciences (ALIM) Indicated Lower After FDA Says ILUVIEN NDA Cannot Be Approved in Present Form
Back to ALIM Stock Lookup
